{
"NDC": {
"NDCCode": "67296-2138-2",
"PackageDescription": "21 TABLET in 1 BOTTLE (67296-2138-2) ",
"NDC11Code": "67296-2138-02",
"ProductNDC": "67296-2138",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Meclizine Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Meclizine Hydrochloride",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20201029",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA213957",
"LabelerName": "Redpharm Drug",
"SubstanceName": "MECLIZINE HYDROCHLORIDE",
"StrengthNumber": "25",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Antiemetic [EPC], Emesis Suppression [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-24",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20201029",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}